Home

Immune Design (IMDZ) Alert: Johnson Fistel Investigates Proposed Sale of Immune Design Corp.; Are Immune Design Shareholders Getting a Fair Deal?

The investigation concerns whether the Immune Design board failed to satisfy its duties to the Compa…

Merck to Acquire Immune Design; Acquisition Bolsters Capabilities in Vaccine Development for Infectious Diseases and Cancer

“Scientists at Immune Design have established a unique portfolio of approaches to cancer immunizatio…

SEC Files Charges in Elaborate Microcap Stock Fraud

“As alleged in our complaint, Magna Group and its co-defendants used fake debt instruments to unlawf…

Investor Alert and Bulletin From SEC Office of Investor Education and Advocacy

Know how to be a better investor. Did you know that active trading and some other very common invest…

COURT ORDERS $1 BILLION JUDGMENT AGAINST OPERATORS OF WOODBRIDGE PONZI SCHEME TARGETING RETAIL INVESTORS

"This resolution accomplishes one of the SEC's core missions to protect retail investors," said Step…

SEC Charges Cognizant and Two Former Executives With FCPA Violations

“Bribery to further corporate goals is an illusory path to long-term success. While always the wron…

FDA Authorizes First Interoperable Insulin Pump Intended to Allow Patients to Customize Treatment Through their Individual Diabetes Management Devices

“Diabetes is a complicated disease that requires close monitoring and carefully tailored treatments.…

FDA Warns Patients and Doctors About Recall of Home-use Test Strips Used with Device to Monitor Blood Thinner Warfarin, Not Authorized for Sale in U.S.

“Monitoring warfarin dosing is a critical part of using the drug properly to prevent and treat blood…

SEC Charges Four Public Companies With Longstanding ICFR Failures

According to the SEC’s orders, year after year, the four companies disclosed material weaknesses in …

Kimberly-Clark Announces Voluntary Recall of U by Kotex® Sleek® Tampons, Regular Absorbency, Throughout U.S. and Canada USA – English

Kimberly-Clark has received reports from consumers of the U by Kotex® Sleek® Tampons, Regular Absorb…

Page 1 of 1012 3 4 5 » ...Last »

Fintech
Benzinga BioTech
Investment News
Stocks to Watch
Finance
Most Popular News Articles
Bitcoin News
Cramers Picks
Technology News
Stocks and Commodities
Daily Technical Analysis
CGC
Featured Stock
Emerging Markets
Economy
Investing
Options
Real Estate News
Nasdaq Stock News
Latest Articles in Real Estate
Mstardom Finance
Food and Drug Administration--Press Releases
What's New: Drugs RSS Feed
OTC Markets Group - News, Filings & Corporate Actions
ECB - European Central Bank
FRB: Press Release - All Releases
Press Releases
St. Louis Fed - Recent Research
Research Announcements – St. Louis Fed Economic Research
Economic Education
Investor Alerts and Bulletins
SEC.gov Updates: Litigation Releases
SEC.gov Updates: Proposed Rules

Envestnet | Tamarac Announces Agreement to Acquire PortfolioCenter® from Schwab Performance Technologies®

21 February 2019 - PRNewswire

CHICAGO, Feb. 21, 2019 /PRNewswire/ -- Envestnet | Tamarac ...

Full story available on Benzinga.com

The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering

20 February 2019 - Shanthi Rexaline

Here's a roundup of top developments in the biotech space over the last 24 hours:

Scaling The Peaks

(Biotech stocks hitting 52-week highs on Feb. 19)

Alector Inc (NASDAQ: ALEC) (IPOed early February) Avedro Inc (NASDAQ: AVDR)(debuted Tuesday) BioDelivery Sciences International, Inc. (NASDAQ: BDSI) Eton Pharmaceuticals Inc (NASDAQ: ETON)( announced an agreement with Bausch Health Companies Inc (NYSE: BHC) to sell U.S. rights to its investigational eye drops EM-100) NxStage Medical, Inc. (NASDAQ: NXTM) Orthofix Medical Inc (NASDAQ: OFIX) PDL BioPharma Inc (NASDAQ: PDLI) Synthorx Inc (NASDAQ: THOR) Down In The Dumps

(Biotech stocks hitting 52-week lows on Feb. 19)

Chimerix Inc (NASDAQ: CMRX) MOTIF BIO PLC/S ADR (NASDAQ: MTFB)(announced an amended agreement with its lender Hercules Capital, which provides for immediate early repayment of $7 million and a $0.5 million repayment on the earlier of 90 days, being May 18, or receipt of funds from an equity raise of $2 million or greater) Stock In Focus Merck's Keytruda Fails In Late-stage Trial For Liver Cancer

Merck & Co., Inc. (NYSE: MRK) said a pivotal Phase 3 study dubbed KEYNOTE-240 that uated its anti-PD-1 therapy Keytruda plus best supportive care for advanced hepatocellular carcinoma in patients, who were previously treated with systemic therapy, did not meet its co-primary endpoints of overall survival and progression-free survival compared with placebo plus best supportive care.

The stock slipped 1.11 percent to $78.36 in after-hours trading.

Novartis' Sandoz Unit Announces U.S. Launch of Generic Drug to Treat Opioid Dependence

Novartis AG (NYSE: NVS) said its generic unit Sandoz has launched ...

Full story available on Benzinga.com

How After-Hours Trading Affects Stock Prices

21 February 2019

Trading stocks during after-hours trading sessions can have a big effect on the share price an investor will pay.

Stocks to Watch: DuPont, Nike, KB Home are stocks to watch

27 June 2014

Among the companies whose shares are expected to see active trade in Friday’s session are DuPont, Nike, and KB Home.

Sun Communities' (SUI) CEO Gary Shiffman on Q4 2018 Results - Earnings Call Transcript

21 February 2019

General Electric's Crown Jewel Soaring Higher

21 February 2019

University of Michigan Endowment Backs Crypto Venture Capital Fund

22 February 2019 - Avi Mizrahi

University of Michigan Endowment Backs Crypto Venture Capital Fund The financial endowment fund of the University of Michigan, one of the oldest and most established academic institutions in the U.S., is the latest institutional investor revealed to have entered the cryptocurrency ecosystem. Its endowment is backing a crypto venture capital fund managed by Andreessen Horowitz. Also Read: In the Daily: Sirin Labs Smartphone, Middle […]

The post University of Michigan Endowment Backs Crypto Venture Capital Fund appeared first on Bitcoin News.

Long-Term Growth Stocks - Cramer's Mad Money (12/11/18)

12 December 2018

Even Apple’s self-driving car safety report is super secretive

22 February 2019 - Sasha Lekach

Apple's autonomous car program is as secretive as ever.

Compare the seven-page safety report Apple submitted to the National Highway Traffic Safety Administration this week to the 43-page color explosion from Waymo, the self-driving car startup from Google parent company Alphabet.

Apple's first page.

Image: apple / nhtsa / screengrab

Waymo's first page.

Image: Waymo

Both talk about each companies' safety practices and guiding principles when it comes to self-driving vehicles, but only one (guess which one) keeps it brief and vague. Other companies like Ford, GM's Cruise, and Nuro also share additional details and include charts, vehicle pictures, and images of — wait for it — people. Read more...

More about Apple, Safety, Autonomous Vehicles, Project Titan, and Tech

ES1!

21 February 2019

Ripple Could go to 100+ USD Next Year (Elliott Wave)

1 September 2018

Like and Follow for more Ideas and updates to this chart. Ripple is in a potential bullish harmonic reversal zone here. There's also a weekly bullish divergent bar, and the weekly momentum is starting to diverge and turn around. We're also within the correct time zone for this wave to end, along with the inside Elliott wave count for wave-(d) matching that of other cryptocurrencies which also appear bullish, some of which have already seen the beginning of a pretty big reversal. This implies that we've likely already hit the bottom on XRP and are beginning to climb now. Potential target is somewhere from 10-150 USD, and could take from 6-10 months. We'll have to see how this continues to develop from here to know what a more precise target will be. I suspect that we'll continue to see very violent waves up, like we've seen in the past, with very long corrections.

CGC triangle formation

19 February 2019

There is no stopping the weed train, at least in the Canada's 9 billion weed market. CGC went from $20's in dec to $50 this month. And I can see a triangle formation on chart. Maybe a breakout in upper 50's next week?

AAPL could lose 61.8% to hit 204 Month SMA @ $60

21 February 2019

Could it really happen - i don't know - but the gap is there

This Tiny Cannabis Company Hits a Tilray Payday

20 February 2019

Top marijuana stock Tilray NASDAQ TLRY flexed its financial muscles today acquiring Manitoba Harvest a natural foods company for up to 419 million Canadian dollars 316 3 million including milestones The acquisition provides Tilray with a platform it can leverage to

Wall Street points to higher open; Dow futures jump 200 points

22 February 2016

Investing.com Investing.com U.S. stock markets pointed to strong gains at the open on Monday, with the Dow futures briefly jumping more than 200 points as a rebound in oil prices boosted market sentiment. The blue chip Dow futures climbed

Fed Minutes & Q4 Earnings

20 February 2019

We remain lacking on normal economic data ahead of today s opening bell not only because Q4 earnings season s deluge has dwindled but because the overhangs of the 5 week government shutdown has continued delays in data such as the January Housing Starts and Building Permits that had

The Case For Staying In The Market -- Especially Growth

21 February 2019

Should I stay or should I go If you ve been singing this 1981 tune by the English punk rock band The Clash to yourself since late September you are not alone In the fourth quarter selloff last year U S equities lost 4 trillion in combined market value For those who had chosen to stay

CSQ Makes Bullish Cross Above Critical Moving Average

20 February 2019

In trading on Wednesday shares of Calamos Strategic Total Return Fund Symbol CSQ crossed above their 200 day moving average of 12 34 changing hands as high as 12 35 per share Calamos Strategic Total Return Fund shares are currently trading up about 0 7 on the day The chart below shows

Another Round of Slight Gains Amid Choppy Session

21 February 2019

The Fed provided a momentary diversion today from our heavy focus on the trade talks in Washington but the major indices still finished slightly positive for the second session in a row Remember back on January 30th when Fed Chair Jerome Powell told us that the Fed would be patient

U.S. Home Sales are Plummeting And Nobody's Sure Why

30 January 2019

The U.S. housing market is crumbling--a worrying indication that an economic catastrophe could be brewing. Yet, nobody seems sure why this is happening in an economy that remains hale and hearty by most measures. But don’t rush to your banker just yet hoping to get an easy deal. Rejections for mortgages and

Immune Design (IMDZ) Alert: Johnson Fistel Investigates Proposed Sale of Immune Design Corp.; Are Immune Design Shareholders Getting a Fair Deal?

21 February 2019 - Glenford Robinson

The investigation concerns whether the Immune Design board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Immune Design shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given that one Wall Street analyst has a $9.00 price target on the stock and the Company has approximately $100 million in cash and no long-term debt.

Statement from FDA Commissioner Scott Gottlieb, M.D., on additional steps by the agency to support the development of safe and effective novel nicotine replacement therapies to help smokers quit cigarettes

21 February 2019

FDA releases the second of two draft guidances aimed at supporting the development of novel nicotine replacement therapies.

FDA Drug Safety Communication: FDA to evaluate increased risk of heart-related death and death from all causes with the gout medicine febuxostat (Uloric)

21 February 2019

The U.S. Food and Drug Administration (FDA) is warning that preliminary results from a safety clinical trial show an increased risk of heart-related death with febuxostat (Uloric) compared to another gout medicine called allopurinol. We required the Uloric drug manufacturer, Takeda Pharmaceuticals, to conduct this safety study when we approved the medicine in 2009. Once we receive the final results from the manufacturer, we will conduct a comprehensive review and will update the public with any new information.

Bonterra Resources Inc. (BONXF: OTCQX International) | Bonterra Resources Announces $30 million Private Placement

21 February 2019

Account of the monetary policy meeting

21 February 2019

Federal Reserve Board permanently bars former employee of J.P. Morgan Chase & Co. from the banking industry

21 February 2019

Federal Reserve Board permanently bars former employee of J.P. Morgan Chase & Co. from the banking industry

Giles Cohen Named Acting Chief Counsel, Office of the Chief Accountant

21 February 2019

The Securities and Exchange Commission today announced that Giles Cohen has been named Acting Chief Counsel, Office of the Chief Accountant (OCA).

Mr. Cohen joined the SEC in 2005 as senior counsel in the Division of Enforcement, and later served as counsel in the Office of Commissioner Luis Aguilar. Mr. Cohen has served as OCA's Deputy Chief Counsel since May 2016.

"Giles is widely respected by his colleagues throughout the Commission for his steady and thoughtful counsel," said Chairman Jay Clayton. "I want to thank him for taking on this important role in support of the Commission and OCA."

"Giles has a deep knowledge of the U.S. financial reporting system, the oversight activities for the Financial Accounting Standards Board and the Public Company Accounting Oversight Board, the disqualification and reinstatement of accountants, and the other responsibilities of OCA," said SEC Chief Accountant Wes Bricker. "Giles is widely known and trusted throughout the Commission not only for his thoughtful counsel and insights to even the most challenging questions, but also for the generosity with which he shares his time and talents with his colleagues."

"I am excited and grateful for this opportunity to continue to work alongside the talented and dedicated staff in the Office of the Chief Accountant as we advance the Commission's mission, including the protection of investors, through the promotion of high quality financial reporting," said Mr. Cohen.

Before joining the SEC, Mr. Cohen served as securities counsel at the law firm of WilmerHale, and prior to that as an attorney at the law firm of Davis Polk and Wardwell. Mr. Cohen received his law degree from the University of Pennsylvania Law School, where he was a comments editor on the University of Pennsylvania Law Review. He received his B.A. in Government from Cornell University.

The Office of the Chief Accountant is responsible for accounting and auditing matters arising in the Commission’s administration of the federal securities laws, such as oversight activities of standard setting organizations and the PCAOB.

Gauging Market Responses to Monetary Policy Communication

14 February 2019

By Kevin L. Kliesen, Brian Levine, Christopher J. Waller in Review.

Chinese Royalties

8 February 2019

Read up on what China pays to use U.S. intellectual property.

2019 AP Economics Conference

12 July 2019

Are you a seasoned AP economics instructor, new to teaching AP econ courses, or simply contemplating teaching them? If so, join us as Federal Reserve economists, AP economics exam readers, exam developers and instructors, and St. Louis Fed economic education staff present a program packed with the information you need to be successful.

Investor Bulletin: 10 Investment Tips for 2019

12 February 2019

Whether you are a first-time investor or have been investing for years, here are 10 tips from the SEC’s Office of Investor Education and Advocacy to help you in 2019.

Mathias Francisco Sandoval Herrera and Maria D. Cidre

21 February 2019

SEC Obtains Final Judgments Against Former CEO and Former CFO of General Cable Corp. Operating Segment

Solicitations of Interest Prior to a Registered Public Offering

19 February 2019

Immune Design (IMDZ) Alert: Johnson Fistel Investigates Proposed Sale of Immune Design Corp.; Are Immune Design Shareholders Getting a Fair Deal?

Merck to Acquire Immune Design; Acquisition Bolsters Capabilities in Vaccine Development for Infectious Diseases and Cancer

“Scientists at Immune Design have established a unique portfolio of approaches to cancer immunization and adjuvant systems designed to enhance the ability of a vaccine to protect against infection, which could meaningfully improve vaccine development,” said Dr. Roger M. Perlmutter, president, Merck Research Laboratories. “This acquisition builds upon Merck’s industry-leading programs that harness the power of the immune system to prevent and treat disease.”

SEC Files Charges in Elaborate Microcap Stock Fraud

“As alleged in our complaint, Magna Group and its co-defendants used fake debt instruments to unlawfully obtain shares in microcap companies, which they then dumped on unsuspecting retail investors,” said Sanjay Wadhwa, Senior Associate Director of the SEC’s New York Regional Office. “This action demonstrates the resolve of the SEC in pursuing fraudsters who use elaborate financing schemes to engage in securities fraud.”

Investor Alert and Bulletin From SEC Office of Investor Education and Advocacy

Know how to be a better investor.
Did you know that active trading and some other very common investing behaviors actually can undermine investment performance? According to researchers, other common investing mistakes include focusing on past performance, favoring investments from your own country, region, state, or company, and holding on to losing investments too long and selling winning investments too soon.

COURT ORDERS $1 BILLION JUDGMENT AGAINST OPERATORS OF WOODBRIDGE PONZI SCHEME TARGETING RETAIL INVESTORS

“This resolution accomplishes one of the SEC’s core missions to protect retail investors,” said Stephanie Avakian, Co-Director of the SEC’s Division of Enforcement. “Mr. Shapiro and other defendants will be held accountable and required to pay substantial penalties for their misconduct.”

“Our complaint charged that when Woodbridge’s fictitious business model collapsed, the company stopped paying investors and filed for Chapter 11 bankruptcy protection,” said Eric I. Bustillo, Director of the SEC’s Miami Regional Office. “The settlement provides for the return of significant funds to investors.”